Question 1

Does Citadel Advisors own CURX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Citadel Advisors holds 95,258 shares of CURX (Curanex Pharmaceuticals), worth $25,262.

Question 2

How many shares of CURX does Citadel Advisors own?

Accepted Answer

As of its Q2 2026 13F, Citadel Advisors holds 95,258 shares of CURX (Curanex Pharmaceuticals).

Question 3

What is Citadel Advisors' CURX position worth?

Accepted Answer

As of its Q2 2026 13F, Citadel Advisors' CURX position is worth $25,262.

Question 4

Is Citadel Advisors buying or selling CURX?

Accepted Answer

In Q2 2026, Citadel Advisors increased its CURX position by 44,699 shares (+88.4%).

Question 5

When did Citadel Advisors first buy CURX?

Accepted Answer

Citadel Advisors first reported CURX in its Q3 2025 13F and has listed it in 4 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	95,258	+88.4%	$25,262	0.0%	$0.27	20
2026-Q1	Decreased	50,559	-51.5%	$25,851	0.0%	$0.51	0
2025-Q4	Increased	104,278	+62.8%	$34,474	0.0%	$0.33	20
2025-Q3	New	64,067	—	$46,128	0.0%	$0.72	31